back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-19 14:58 Tx date 2024-04-19 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+277,778 vol $0.18 each |
3,902,778 | |
| Filed 2024-04-19 14:58 Tx date 2024-04-19 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+138,889 vol |
138,889 | |
| Filed 2024-04-19 14:56 Tx date 2023-02-01 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-1,000,000 vol |
0 | |
| Filed 2023-03-28 21:26 Tx date 2023-03-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,500
+100,000 vol $0.185 each |
250,000 | |
| Filed 2023-02-23 19:54 Tx date 2023-02-23 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+50,000 vol $0.08 each |
150,000 | |
| Filed 2022-02-01 17:14 Tx date 2022-01-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+100,000 vol $0.06 each |
100,000 | |
| Filed 2022-01-31 13:41 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-11 15:55 Tx date 2022-01-05 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,500,000 vol |
2,500,000 | |
| Filed 2021-05-14 14:42 Tx date 2021-05-12 |
$PSYC
Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) |
Kadysh, Nicholas
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+375,000 vol |
1,500,000 | |
| Filed 2021-05-14 14:41 Tx date 2021-05-12 |
$PSYC
Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) |
Kadysh, Nicholas
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-37,500
-375,000 vol $0.10 each |
375,000 | |
| Filed 2020-08-05 17:10 Tx date 2020-08-05 |
$DPH
Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) |
Kadysh, Nicholas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
750,000 | |
| Filed 2020-08-05 17:09 Tx date 2020-05-05 |
$DPH
Psyched Wellness Ltd. (formerly Duncan Park Holdings Corporation) |
Kadysh, Nicholas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-25 16:36 Tx date 2020-05-22 |
$DPH
Duncan Park Holdings Corporation |
Kadysh, Nicholas
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$7,500
+75,000 vol $0.10 each |
1,125,000 | |
| Filed 2020-05-07 15:36 Tx date 2020-05-05 |
$DPH
Duncan Park Holdings Corporation |
Kadysh, Nicholas
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$3,375
+675,000 vol $0.005 each |
1,050,000 | |
| Filed 2020-05-07 15:35 Tx date 2020-05-05 |
$DPH
Duncan Park Holdings Corporation |
Kadysh, Nicholas
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$67,500
+675,000 vol $0.10 each |
||
| Filed 2020-05-06 19:01 Tx date 2020-05-05 |
$DPH
Duncan Park Holdings Corporation |
Kadysh, Nicholas
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$67,500
+675,000 vol $0.10 each |
||
| Filed 2020-05-06 19:01 Tx date 2020-05-05 |
$DPH
Duncan Park Holdings Corporation |
Kadysh, Nicholas
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$67,500
+675,000 vol $0.10 each |
1,050,000 | |
| Filed 2020-05-06 19:01 Tx date 2020-05-05 |
$DPH
Duncan Park Holdings Corporation |
Kadysh, Nicholas
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
375,000 |